Still River Systems has changed its name and look to reflect the company’s transition from a research and development organization to the commercial manufacturer of the MEVION S250TM Proton Therapy System. Proton therapy is widely regarded as the optimal means of delivering therapeutic radiation to treat a variety of cancers, but is not widely available because of the immense size, enormous expense, and sheer complexity of traditional proton therapy systems. Mevion eliminates these obstacles! To learn more, see www.mevion.com.